Mr Stephen Sheau-yang Gee, MD in Hon., HI - Medicare Ophthalmology

Mr Stephen Sheau-yang Gee, MD is a medicare enrolled "Ophthalmology" physician in Hon., Hawaii. He went to University Of Iowa, Rj & L Carver College Of Medicine and graduated in 1982 and has 42 years of diverse experience with area of expertise as Ophthalmology. His current practice location is 1210 Ward Ave., Hon., Hawaii. You can reach out to his office (for appointments etc.) via phone at (808) 538-1179.

Mr Stephen Sheau-yang Gee is licensed to practice in Hawaii (license number MD5887) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1821188590.

Contact Information

	Mr Stephen Sheau-yang Gee, MD
	1210 Ward Ave., Hon., HI 96814-1422
	(808) 538-1179
	(808) 537-5782

Physician's Profile

Full Name	Mr Stephen Sheau-yang Gee
Gender	Male
Speciality	Ophthalmology
Experience	42 Years
Location	1210 Ward Ave., Hon., Hawaii
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Mr Stephen Sheau-yang Gee attended and graduated from University Of Iowa, Rj & L Carver College Of Medicine in 1982

NPI Data:

NPI Number: 1821188590
Provider Enumeration Date: 10/13/2006
Last Update Date: 04/06/2011

Medicare PECOS Information:

PECOS PAC ID: 9739356510
Enrollment ID: I20120119000049

Medical Identifiers

Medical identifiers for Mr Stephen Sheau-yang Gee such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1821188590	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207W00000X	Ophthalmology	MD5887 (Hawaii)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
The Queens Medical Center	Honolulu, HI	Hospital

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mr Stephen Sheau-yang Gee is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mr Stephen Sheau-yang Gee, MD 1210 Ward Ave, Hon., HI 96814-1422 Ph: (808) 538-1179	Mr Stephen Sheau-yang Gee, MD 1210 Ward Ave., Hon., HI 96814-1422 Ph: (808) 538-1179

News Archive

Clinical Data raises $47.4 million through public offering of shares

Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $47.4 million through the public offering of 2,750,000 newly issued shares of its common stock at a price of $17.25 per share. All of the shares are being offered by Clinical Data, Inc.

Senate compounding pharmacy oversight bill faces 'Obamacare' test

A year after a meningitis outbreak from contaminated pain injections killed at least 64 people and sickened hundreds, Congress is ready to increase federal oversight over compounding pharmacies that custom-mix medications.

Sucampo launches RESCULA Eye Drops in the U.S.

Sucampo Pharmaceuticals, Inc. announced that RESCULA Eye Drops had been launched in the U.S. market.

Expert warns that COVID-19 cases in the UK could reach 50,000 per day

In the United Kingdom, health experts said that the country could face an exponentially growing death rate from COVID-19 within weeks unless urgent action is taken to control the spread of the virus. At present, the country has the highest official COVID-19 death toll in Europe and the fifth-largest across the globe.

Osteopontin plays a role in X-linked hypophosphatemia

Diagnosed in toddlers, X-linked hypophosphatemia (XLH) is the most common form of heritable rickets, in which soft bones bend and deform, and tooth abscesses develop because infections penetrate soft teeth that are not properly calcified. Researchers at McGill University and the Federal University of Sao Paulo have identified that osteopontin, a major bone and tooth substrate protein, plays a role in XLH. Their discovery may pave the way to effectively treating this rare disease.

Mr Stephen Sheau-yang Gee, MD - Medicare Ophthalmology in Hon., HI